Shockwave Medical Inc (SWAV)
330.38
+0.38
(+0.12%)
USD |
NASDAQ |
May 03, 16:00
330.38
0.00 (0.00%)
After-Hours: 20:00
Shockwave Medical Enterprise Value: 12.10B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 12.10B |
| May 02, 2024 | 12.08B |
| May 01, 2024 | 12.08B |
| April 30, 2024 | 12.09B |
| April 29, 2024 | 12.06B |
| April 26, 2024 | 12.08B |
| April 25, 2024 | 12.04B |
| April 24, 2024 | 12.04B |
| April 23, 2024 | 12.03B |
| April 22, 2024 | 12.03B |
| April 19, 2024 | 12.04B |
| April 18, 2024 | 11.99B |
| April 17, 2024 | 11.99B |
| April 16, 2024 | 11.99B |
| April 15, 2024 | 11.97B |
| April 12, 2024 | 12.00B |
| April 11, 2024 | 12.01B |
| April 10, 2024 | 12.07B |
| April 09, 2024 | 11.98B |
| April 08, 2024 | 11.92B |
| April 05, 2024 | 11.95B |
| April 04, 2024 | 11.71B |
| April 03, 2024 | 11.74B |
| April 02, 2024 | 11.71B |
| April 01, 2024 | 11.73B |
| Date | Value |
|---|---|
| March 28, 2024 | 11.92B |
| March 27, 2024 | 11.81B |
| March 26, 2024 | 11.56B |
| March 25, 2024 | 10.48B |
| March 22, 2024 | 10.25B |
| March 21, 2024 | 10.41B |
| March 20, 2024 | 10.42B |
| March 19, 2024 | 10.18B |
| March 18, 2024 | 10.10B |
| March 15, 2024 | 9.988B |
| March 14, 2024 | 9.698B |
| March 13, 2024 | 9.815B |
| March 12, 2024 | 9.640B |
| March 11, 2024 | 9.380B |
| March 08, 2024 | 9.154B |
| March 07, 2024 | 9.319B |
| March 06, 2024 | 9.269B |
| March 05, 2024 | 9.158B |
| March 04, 2024 | 9.483B |
| March 01, 2024 | 9.592B |
| February 29, 2024 | 9.497B |
| February 28, 2024 | 9.560B |
| February 27, 2024 | 9.594B |
| February 26, 2024 | 9.460B |
| February 23, 2024 | 9.496B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
554.16M
Minimum
Mar 20 2020
12.10B
Maximum
May 03 2024
5.383B
Average
6.092B
Median
Mar 04 2022
Enterprise Value Benchmarks
| Boston Scientific Corp | 115.63B |
| AtriCure Inc | 966.61M |
| Masimo Corp | 7.992B |
| Perspective Therapeutics Inc | 1.055B |
| Xtant Medical Holdings Inc | 126.76M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 44.30M |
| Revenue (Quarterly) | 202.98M |
| Total Expenses (Quarterly) | 159.70M |
| EPS Diluted (Quarterly) | 1.16 |
| Gross Profit Margin (Quarterly) | 87.53% |
| Profit Margin (Quarterly) | 21.83% |
| Earnings Yield | 1.17% |
| Operating Earnings Yield | 1.26% |
| Normalized Earnings Yield | 1.171 |